Mesa Laboratories (MLAB) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free MLAB Stock Alerts $123.79 +1.57 (+1.28%) (As of 12:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 1:18 AM | americanbankingnews.comMesa Laboratories (MLAB) Set to Announce Earnings on FridayMay 10, 2024 | americanbankingnews.comMesa Laboratories (NASDAQ:MLAB) Share Price Passes Above Two Hundred Day Moving Average of $100.36April 28, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Short Interest UpdateMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 156,000 shares, a decrease of 18.3% from the March 31st total of 191,000 shares. Based on an average trading volume of 44,200 shares, the short-interest ratio is presently 3.5 days.April 18, 2024 | finance.yahoo.comThe past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitableApril 11, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Raymond James & AssociatesRaymond James & Associates lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 30.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 47,019 shares of the medical instruments supplApril 10, 2024 | marketbeat.comConestoga Capital Advisors LLC Buys 48,253 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Conestoga Capital Advisors LLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 578,463 shares of the medical instruments supplier's stock after purchasing an additional 48April 8, 2024 | globenewswire.comMESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTESApril 6, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Plans $0.16 Quarterly DividendMesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Thursday, April 4th. Stockholders of record on Friday, May 31st will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, June 14th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend is Friday, May 31st.April 4, 2024 | globenewswire.comMESA LABS DECLARES QUARTERLY DIVIDENDApril 4, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) PT Raised to $130.00 at Evercore ISIEvercore ISI upped their price target on Mesa Laboratories from $124.00 to $130.00 and gave the stock an "outperform" rating in a research report on Thursday.April 3, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Trading 4.7% Higher Mesa Laboratories (NASDAQ:MLAB) Stock Price Up 4.7%April 2, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 7.8%Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 7.8%April 1, 2024 | globenewswire.comMesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024March 30, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Sees Significant Decrease in Short InterestMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 196,300 shares, a decline of 17.2% from the February 29th total of 237,200 shares. Based on an average daily trading volume, of 52,800 shares, the short-interest ratio is currently 3.7 days.March 18, 2024 | marketbeat.comComerica Bank Purchases New Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Comerica Bank bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 46,147 shares of the medical instrumentsMarch 15, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Trading 3.4% Higher Mesa Laboratories (NASDAQ:MLAB) Shares Up 3.4%March 15, 2024 | globenewswire.comMesa Labs Releases Second Annual Responsible Business Program BrochureMarch 6, 2024 | marketbeat.comKennedy Capital Management LLC Increases Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Kennedy Capital Management LLC increased its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 42.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 109,496 shares of the medical instruments suppMarch 5, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stock Holdings Cut by Ranger Investment Management L.P.Ranger Investment Management L.P. reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 3.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 223,993 shares of the medical instruments suppFebruary 29, 2024 | wsj.comMesa Laboratories Inc.February 26, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Declares Quarterly Dividend of $0.16Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Tuesday, January 2nd. Shareholders of record on Thursday, February 29th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, March 15th. This represents a $0.64 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend is Wednesday, February 28th.February 23, 2024 | benzinga.comMesa Laboratories Stock (NASDAQ:MLAB) Dividends: History, Yield and DatesFebruary 19, 2024 | finance.yahoo.comMesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech SpendingFebruary 8, 2024 | finance.yahoo.comResults: Mesa Laboratories, Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsFebruary 5, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Shares Up 2.6%Mesa Laboratories (NASDAQ:MLAB) Trading Up 2.6%February 5, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Shares Up 2.6%Mesa Laboratories (NASDAQ:MLAB) Trading Up 2.6%February 5, 2024 | markets.businessinsider.comHere's what Wall Street expects from Mesa Laboratories's earningsFebruary 5, 2024 | msn.comMesa Laboratories Non-GAAP EPS of $2.02 beats by $0.32, revenue of $53.47M misses by $1.13MFebruary 5, 2024 | finance.yahoo.comMesa Laboratories Inc (MLAB) Faces Revenue Dip Amidst Strategic AcquisitionsFebruary 5, 2024 | finance.yahoo.comMesa Labs (MLAB) Lags Q3 Earnings and Revenue EstimatesFebruary 4, 2024 | marketbeat.comL2 Asset Management LLC Purchases New Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)L2 Asset Management LLC bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 20,192 shares of the medical instruments supplier's stock, valued at approxiFebruary 2, 2024 | benzinga.comEarnings Preview: Mesa LaboratoriesJanuary 29, 2024 | marketbeat.comMesa Laboratories (MLAB) Set to Announce Earnings on MondayMesa Laboratories (NASDAQ:MLAB) will be releasing earnings before the market opens on Monday, February 5, Zacks reports.January 27, 2024 | marketbeat.comSeizert Capital Partners LLC Invests $1.35 Million in Mesa Laboratories, Inc. (NASDAQ:MLAB)Seizert Capital Partners LLC purchased a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 12,818 shares of the medical instruments sJanuary 24, 2024 | seekingalpha.comAndvari Associates Q4 2023 LetterJanuary 11, 2024 | marketbeat.comConestoga Capital Advisors LLC Sells 46,013 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Conestoga Capital Advisors LLC lowered its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 530,210 shares of the medical instruments supplier's stock after selling 46,013 shares during theJanuary 5, 2024 | benzinga.comMesa Laboratories Stock (NASDAQ:MLAB), Analyst Ratings, Price Targets, PredictionsJanuary 5, 2024 | msn.comEvercore ISI Group Upgrades Mesa Laboratories (MLAB)January 5, 2024 | finance.yahoo.comWhat Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Doing?January 4, 2024 | markets.businessinsider.comEvercore ISI Group Upgrades Mesa Laboratories: Here's What You Need To KnowJanuary 4, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Upgraded to "Outperform" at Evercore ISIEvercore ISI upgraded Mesa Laboratories from an "in-line" rating to an "outperform" rating and increased their target price for the company from $100.00 to $125.00 in a research report on Thursday.January 3, 2024 | finanznachrichten.deMesa Laboratories, Inc.: Mesa Labs Completes the Acquisition of GKE Science & Technology Co.January 3, 2024 | finance.yahoo.comMesa Labs Completes the Acquisition of GKE Science & Technology Co.December 30, 2023 | marketbeat.comShort Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Decreases By 21.9%Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 230,200 shares, a decline of 21.9% from the November 30th total of 294,600 shares. Based on an average trading volume of 49,000 shares, the short-interest ratio is presently 4.7 days.December 27, 2023 | morningstar.comMesa Laboratories Inc MLABDecember 19, 2023 | marketbeat.comBrian David Archbold Sells 1,500 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) SVP Brian David Archbold sold 1,500 shares of the business's stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $112.36, for a total value of $168,540.00. Following the completion of the transaction, the senior vice president now directly owns 558 shares of the company's stock, valued at approximately $62,696.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.December 14, 2023 | finance.yahoo.comMesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024November 6, 2023 | finance.yahoo.comMesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 RevenuesOctober 25, 2023 | finance.yahoo.comMesa Laboratories, Inc. (MLI.F)October 16, 2023 | stockhouse.comMesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry MLAB Media Mentions By Week MLAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLAB News Sentiment▼0.000.42▲Average Medical News Sentiment MLAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLAB Articles This Week▼11▲MLAB Articles Average Week Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SENS News ZYME News SVRA News AUNA News SLN News VREX News DH News QTRX News LYEL News EYPT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLAB) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
